Founder & CEO of JoinCare.
Academician and global innovation strategist.
Focused on life-science translation, intelligent industry and future research systems.
I have become careful with big technology promises.
Every new wave brings real potential.
It also brings a lot of noise.
So I try not to ask what is fashionable.
I ask what problem is actually being solved.
This is why I decided to build JoinCare.
Not as another platform chasing attention.
But as a way to help researchers, medical experts, contributors, and communities organize around evidence, risk, and long-term value.
🤝 JoinCare × Roam
We’re excited to partner with Roam @weRoamxyz , a DePIN wireless platform using OpenRoaming and eSIM to deliver secure, seamless global connectivity.
Together, we’ll explore DeSci outreach, joint community initiatives, and future platform integrations.
It was a pleasure to exchange views with Dr. Masanori Isogawa and the team at NIID.
Scientific progress begins with open dialogue, mutual respect, and a willingness to learn from one another.
European news outlet Brussels Standard covered JoinCare’s recent visit to Japan’s NIID.
Our CEO Peter Sachsenmeier @PeterJoinCare met Dr. Masanori Isogawa to discuss virology, infectious disease prevention, and early-stage biomedical innovation.
Read the full story 👇https://t.co/dlseyfy9s6
This is the layer we need to take more seriously.
Better expert review.
Better research support.
Better communication.
Responsible AI tools.
Communities that understand before they judge.
JoinCare Strategic Seed Round 🧬
JoinCare has closed its strategic seed round, with backing from @candaqcom, @Titans_ventures, and DI Foundation @Didotxyz_ .
The round will support the next stage of JoinCare’s biomedical innovation platform.
JoinCare is pleased to announce a strategic investment from @Titans_ventures and DI Foundation (@Didotxyz_).
Together, we will strengthen JoinCare’s global Web3 and DeSci network, helping more early-stage biomedical projects access scientific review, ecosystem resources, and open incubation support.
Building better pathways for biomedical innovation in Web3.
More to come.
JoinCare’s closed beta is opening soon.
A small group will get early access, test key features, and qualify for benefits reserved for early contributors.
Early contributions will carry more weight in future reward allocations.
Limited spots. More details soon. 🔒
Biology is becoming an industrial capability.
That means the next era of healthcare will depend not only on science, but on validation, production, regulation, and trust.
Meet the new JoinCare.
A refreshed identity. A new website. The same mission to fund the future of medicine.
Explore the new JoinCare: https://t.co/iKxYuXxW52
A hypothesis is only the beginning.
Early science needs a path to become a project people can review, test, and fund.
That is where DeSci can make a difference.
#DeSci
The future of medicine will not be built by algorithms alone.
It will be built by people and institutions that know how to connect science, capital, policy, and trust.
That is the space I am watching.
We have seen this pattern before.
Machines changed production.
Software changed coordination.
Data changed decision-making.
Now biology is entering the industrial conversation.